Human tissue cultures of lung cancer predict patient susceptibility to immune-checkpoint inhibition

Despite novel immunotherapies being approved and established for the treatment of non-small cell lung cancer (NSCLC), ex vivo models predicting individual patients’ responses to immunotherapies are missing. Especially immune modulating therapies with moderate response rates urge for biomarkers and/o...

Descripción completa

Detalles Bibliográficos
Autores principales: Junk, David, Krämer, Sebastian, Broschewitz, Johannes, Laura, Hennig, Massa, Chiara, Moulla, Yousef, Hoang, Ngoc Anh, Monecke, Astrid, Eichfeld, Uwe, Bechmann, Ingo, Lordick, Florian, Seliger, Barbara, Kallendrusch, Sonja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464600/
https://www.ncbi.nlm.nih.gov/pubmed/34564709
http://dx.doi.org/10.1038/s41420-021-00651-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464600/
https://www.ncbi.nlm.nih.gov/pubmed/34564709
http://dx.doi.org/10.1038/s41420-021-00651-5

Ejemplares similares